For research use only. Not for therapeutic Use.
Cefodizime(Cat No.:R039633) is a third-generation cephalosporin antibiotic used for its antibacterial properties. Its action targets involve inhibiting bacterial cell wall synthesis, specifically the synthesis of peptidoglycan, an essential component of bacterial cell walls. The mode of action leads to bacterial cell wall disruption, ultimately causing cell lysis and death. Pharmacologically, Cefodizime is effective against a broad spectrum of gram-positive and gram-negative bacteria, making it useful in treating various bacterial infections. Its applications include the treatment of respiratory tract infections, urinary tract infections, skin, and soft tissue infections, and other infections caused by susceptible bacteria.
Catalog Number | R039633 |
CAS Number | 69739-16-8 |
Synonyms | 7-(α-(Z)-Methoxyimino-α-(2-aminothiazol-4-yl)acetamido)-3-((5-carboxymethyl-4-methylthiazol-2-yl)thiomethyl)-3-cephem-4-carboxylic Acid; (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazol |
Molecular Formula | C20H20N6O7S4 |
Purity | ≥95% |
Target | Penicillin-binding protein (PBP) |
Storage | Store at +4C |
IUPAC Name | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
InChI | InChI=1S/C20H20N6O7S4/c1-7-10(3-11(27)28)37-20(22-7)36-5-8-4-34-17-13(16(30)26(17)14(8)18(31)32)24-15(29)12(25-33-2)9-6-35-19(21)23-9/h6,13,17H,3-5H2,1-2H3,(H2,21,23)(H,24,29)(H,27,28)(H,31,32)/b25-12-/t13-,17-/m1/s1 |
InChIKey | XDZKBRJLTGRPSS-BGZQYGJUSA-N |
SMILES | CC1=C(SC(=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O)CC(=O)O |